BIO-TECHNE Corp Logo

BIO-TECHNE Corp

Develops reagents and instruments for life sciences research and clinical diagnostic markets.

TECH | NDAQ

Overview

Corporate Details

ISIN(s):
US09073M1045
LEI:
Country:
United States of America
Address:
614 MCKINLEY PL N E, 55413 MINNEAPOLIS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Bio-Techne Corporation is a global life sciences company that develops, manufactures, and supplies high-quality reagents, instruments, and services for the research and clinical diagnostic markets. The company empowers scientists and clinicians by providing innovative workflow solutions designed to accelerate discovery and improve patient health. Its portfolio includes a wide range of research tools, such as recombinant antibodies and assays, as well as automated instruments for protein analysis, identity, and purity assessment. Bio-Techne focuses on providing reproducible and consistent results, with key applications in areas like next-generation cell and gene therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all BIO-TECHNE Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIO-TECHNE Corp

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIO-TECHNE Corp via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Clearside Biomedical, Inc. Logo
Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.
United States of America CLSD
Clene Inc. Logo
Developing nanocrystal therapies for neurodegenerative diseases like ALS and MS.
United States of America CLNN
Climb Bio, Inc. Logo
Clinical-stage biotech developing monoclonal antibodies for immune-mediated diseases.
United States of America CLYM
CMG Pharmaceutical Co., Ltd. Logo
Develops and manufactures prescription drugs, specializing in Oral Thin Film (OTF) technology.
South Korea 058820
Cocrystal Pharma, Inc. Logo
Develops novel antiviral drugs for influenza, coronaviruses, norovirus, and hepatitis C.
United States of America COCP
Co-Diagnostics, Inc. Logo
Develops patented PCR solutions for accurate infectious disease diagnostics.
United States of America CODX
co.don AG Logo
Develops personalized cartilage cell transplants for minimally invasive joint repair.
Germany CNW
Coeptis Therapeutics Holdings, Inc. Logo
Develops cell therapy platforms for cancer, autoimmune, and infectious diseases.
United States of America COEP
COGNITION THERAPEUTICS INC Logo
Clinical-stage biopharma developing small-molecule drugs for Alzheimer's and dementia.
United States of America CGTX
Coherus Oncology, Inc. Logo
Commercial-stage biopharma developing immuno-oncology therapies for hard-to-treat cancers.
United States of America CHRS

Talk to a Data Expert

Have a question? We'll get back to you promptly.